Dr. Cohen on Biomarker Testing in Head and Neck Cancer

Ezra Cohen, MD
Published Online: Friday, Oct 14, 2016



Ezra Cohen, MD, associate director, Moores Cancer Center, professor of Medicine, University of California, San Diego Health System, discusses biomarker testing in patients with head and neck cancer.

Biomarkers will play a major role in the treatment of patients with head and neck cancer, according to Cohen. If novel agents such as afatinib (Gilotrif) are approved for treatment in this setting, then the next step will focus strongly on biomarker testing.

A priori testing, such as p16 status, will be important, says Cohen. Moreover, fluorescence in situ hybridization is commercially available and could be used, as well. Overall, the goal is to use use these biomarkers to select patients who may be good candidates for specific agents, says Cohen.


Ezra Cohen, MD, associate director, Moores Cancer Center, professor of Medicine, University of California, San Diego Health System, discusses biomarker testing in patients with head and neck cancer.

Biomarkers will play a major role in the treatment of patients with head and neck cancer, according to Cohen. If novel agents such as afatinib (Gilotrif) are approved for treatment in this setting, then the next step will focus strongly on biomarker testing.

A priori testing, such as p16 status, will be important, says Cohen. Moreover, fluorescence in situ hybridization is commercially available and could be used, as well. Overall, the goal is to use use these biomarkers to select patients who may be good candidates for specific agents, says Cohen.

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Clinical Vignette Series: 34th Annual Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow®Feb 28, 20182.0
Community Practice Connections™: Translating Research to Inform Changing Paradigms: Assessment of Emerging Immuno-Oncology Strategies and Combinations Across Lung, Head and Neck, and Bladder CancersApr 28, 20182.0
Publication Bottom Border
Border Publication
$emailPop$